Form 4 · Filed Jul 20, 2026, 10:08 PM UTC
ARTV/Artiva Biotherapeutics, Inc.
RA CAPITAL MANAGEMENT, L.P. — director
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
2 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jul 17, 2026 | P | buy | 7,882 | $9 | $70,544 | 16,977,927 |
| Jul 16, 2026 | P | buy | 152,472 | $9 | $1,361,575 | 16,970,045 |
Source: SEC EDGAR raw filing ↗ · Accession 0001231919-26-000774